Social Media-Driven Short Squeeze Candidates
This collection features companies with high short interest that could potentially experience rapid price surges if targeted by retail investors on social media. Our analysts have carefully selected these stocks based on their similarity to recent phenomena like the Opendoor Technologies rally. These companies have the characteristics that often attract coordinated buying campaigns.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This group capitalizes on the growing influence of social media on stock prices. We've identified companies with high short interest that share similarities with previous "meme stocks" that experienced dramatic rallies. These companies tend to be recognizable to consumers and have attracted significant bearish positions from institutional investors.
What You Need to Know
These stocks carry higher-than-average volatility and risk. Price movements may be driven more by market sentiment and social momentum than by business fundamentals. While potential gains can be substantial during a short squeeze, timing is unpredictable and price corrections can be equally dramatic.
Why These Stocks
We selected companies across various sectors including financial services, real estate, and biotechnology that have significant short interest. These businesses operate in industries where retail investors often have direct experience or emotional connection, making them potential candidates for coordinated buying pressure that could trigger rapid price increases.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+389.72%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 389.72% over the next year.
Stocks Rated Buy by Analysts
14 of 16 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Explosive Potential
These heavily shorted stocks could experience dramatic price surges in a matter of days or even hours if they catch the attention of social media communities. The Opendoor rally showed how quickly these movements can develop.
Power of the Crowd
When retail investors coordinate on social platforms, they can create price momentum that overwhelms institutional short positions. This theme puts you ahead of potential social media-fueled rallies that could transform stock prices.
Social Sentiment Advantage
These companies operate in industries where everyday consumers have direct experience or emotional connection, making them prime candidates for viral attention. Being positioned before social media attention hits could offer significant opportunities.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.